MONDAY, SEPTEMBER 26, 2016

FDA approves Flublok influenza vaccine for 2015-16

The FDA has approved Flublok influenza vaccine for 2015-16 flu season. | Courtesy of medicalexpo.com
Protein Sciences Corp. recently announced that the U.S. Food and Drug Association (FDA) has approved the company’s Flublok influenza vaccine composition for the 2015-16 flu season.

Every year, influenza vaccine producers must gain FDA approval for any changes to their vaccines. The vaccines must be changed each year to include protection against current flu strains in the new season’s batch of vaccines.

For 2015 and 2016, there were two strain changes. Producers of traditional, egg-based vaccines may have delays during vaccine production because some years have two or more new flu strains, and traditional manufacturing technology is a lengthy process. This is what happened to the Southern Hemisphere last spring when influenza vaccine deliveries were delayed for more than a month.

Flublok vaccine development technology was a quick process and will allow vaccine distribution to be in the middle of August.

"We are extremely pleased with the early approval of the 2015/16 Flublok formulation," Protein Sciences Corp. President and CEO Manon Cox said. "We expect Flublok to be available in Target pharmacies and other retail chains before most other vaccines this year. Flublok is approved for use in everyone 18 years and older."

Organizations in this story

Protein Sciences Corporation 1000 Research Pkwy Meriden, CT 06450

Get notified the next time we write about Protein Sciences Corporation!